Biologics Use Not Associated With Increased Mortality or Readmission Risk After Major Surgery in RA
Researchers evaluated the effect of biologics and glucocorticoids on outcomes after major surgeries in rheumatoid arthritis.
All articles by Rheumatology Advisor Contributing Writer
Assessing Clinical Usefulness of Vascular Biomarkers in Risk Stratification for Systemic Sclerosis
Researchers assessed the clinical usefulness of specific biomarkers in risk stratification for vascular complications Identifying biomarkers that predict risk for pulmonary hypertension or ischemic digital lesions may be useful in monitoring the development of systemic sclerosis in patients.
ESC Working Group on Cardiovascular Pharmacotherapy Releases Recommendations for Lipid Management in RA
The position paper developed by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy provides recommendations for lipid management in rheumatoid arthritis.
Diarrheagenic E coli Increases Risk for Reactive Arthritis and Musculoskeletal Symptoms Among Travelers
Researchers evaluated the association between diarrheagenic E coli and development of reactive arthritis and musculoskeletal symptoms among international travelers.
Q&A: Applications of a Novel Joint Preservation Technology in Glenohumeral Osteoarthritis
In this interview, Gregory P Nicholson, MD, discusses the applications of a novel joint preservation technology in glenohumeral osteoarthritis.
Higher BMI Associated With Reduced Foot Health in Patients With Rheumatoid Arthritis
Patients with rheumatoid arthritis and a higher BMI were shown to have increased foot pain and foot-related activity limitations.
LDL-C Lowering Effect of Statins Partly Accounts for Related Improvements in BMD
The improvements in estimated and total body bone mineral density observed with statin treatment may be partly accounted for by their low-density lipoprotein cholesterol-lowering effect.
Does TNFi Monotherapy for RA Become More Efficacious With Age?
Findings in this study should help alleviate concerns about TNFi monotherapy immunogenicity in older patients with RA.
Treatment Change Uncommon Despite Elevated Disease Activity in RA
One- to two-thirds of patients failed to modify rheumatoid arthritis treatment, even when they were in moderate or high disease activity.
Outcomes Associated With Inflammatory Arthritis Diagnosis Before, During, and After Pregnancy
Peri-partum complications in RA/PsA patients do not significantly increase in patients with good disease control.
-
Loading...
-
Loading...
Next post in Rheumatoid Arthritis Advisor
